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1. Introduction 
The common precursor of corticotropin (ACTH) 
and/3-1ipotropin 03-LPH) [1-8] contains multiple bio- 
logically active peptides. We have elucidated the whole 
primary structure of the bovine ACTH-t3-LPH precur- 
sor by determining the nucleotide sequence of 
cloned DNA complementary to the mRNA coding for 
the precursor protein [9]. Using this bovine cDNA as 
a hybridization probe, we have then isolated the 
entire bovine gene encoding the ACTH-13-LPH pre- 
cursor as a set of genomic DNA fragments and have 
determined its structural organization [ 10,11 ]. We 
have now isolated and characterized a human genomic 
DNA fragment containing the entire ACTH-t3-LPH 
precursor gene. The human gene, like the bovine coun- 
terpart, consists of 3 exons (mRNA-coding sequences) 
divided by 2 large introns (intervening sequences). 
Nucleotide sequence analysis of the whole exons has 
revealed the complete mRNA and amino acid sequences 
of the human ACTH-/3-LPH precursor. 
2. Materials and methods 
DNA was prepared from a human placenta s in 
[ 12]. Human genomic DNA clones were isolated as in 
[ 10,11,13]. All cloning procedures were performed 
under P2 containment by using the approved EK2 
Abbreviations: ACTH, corticotropin; ~-LPH, 13-1ipotropin; 
3,-LPH, 7-1ipotropin; a-MSH, a-melanotropin; ~3-MSH, t3-mela- 
notropin; 7-MSH, 7-melanotropin; CLIP, corticotropin-like 
intermediate lobe peptide 
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host/vector systems, XgtWES • XB/DP50supF and 
pBR322/× 1776, according to the Japanese guidelines 
for recombinant DNA research. Restriction mapping 
was accomplished by combining data obtained by 
digestion and subsequent gel electrophoresis of both 
5'-end-labelled and unlabelted DNA fragments and by 
blot hybridization analysis [14]; the procedures used 
were as in [10,11], except hat prehybridization, 
hybridization and filter washing were conducted at 
60°C. DNA sequencing was carried out by the proce- 
dure in [15]. Reagents were obtained as in [11]. 
3. Results and discussion 
Human placental DNA was digested to completion 
with EcoRI and electrophoresed on 0,7% agarose gel. 
Blot hybridization analysis with the cloned bovine 
eDNA (PstI-excised insert of plasmid pSNAC20 [8]) 
as a probe displayed asingle hybridization-positive 
band corresponding to a size of ~11.5 kilobase pairs. 
Therefore, a fraction of EcoRI-digested human pla- 
cental DNA having a size of 10-12 kilobase pairs was 
isolated by preparative agarose gel electrophoresis and 
used for cloning into bacteriophage XgtWES. Recom- 
binant phage that exhibited apositive hybridization 
signal with the bovine eDNA probe were screened, and 
the 11.5-kilobase pair EcoRI fragment derived from 
file phage isolated was subcloned in plasmid pBR322. 
A restriction map of the cloned 1 1.5-kilobase pair 
EcoRI fragment was constructed (riga A) and DNA 
fragments containing an mRNA-coding sequence were 
identified by blot hybridization analysis with the 
bovine cDNA or with a bovine genomic DNA frag- 
ment containing exon 1 (1.7-kilobase pair BamHI frag- 
ment [11 ]) as a probe. The 3 hybridization-positive 
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Fig.t. Restriction mapping of cloned human genomic DNA containing the ACTH-#-LPH precursor gene and sequencing strategy' 
(A) 11.5-kilobase pair Eco RI fragment; (B-D)  portions of the 11.5-kilobase pair EcoRI fragment containing exon i,  exon 2 and 
exon 3, respectively. The direction of transcription is from left-r ight. Scales are given in basepairs (bp) on the right side of  each 
restriction map. For reference, the locations of exons are shown by closed boxes. Only relevant restriction sites are displayed fo:: 
PVull and Hinfl (A); DdeI (B); Ddel and Avail (C); and Tacl, HaelII, RsaI, Avail, AvaI, BstNl, Alul and IlinfI (D). The horizontz'l 
arrows beneath the restriction maps in (B-D)  indicate the direction and extent of sequence determinations. 
u- l l~  
Fig.2. Nucleotide sequences of the exons and their surrounding regions of the human ACTH-17-LPH precursor gene and compar -
son with those of the bovine gene. The nucleotide sequence of the human message strand, together with the deduced amino acid 
sequence, is shown, and the nucleotide and amino acid differences found in the bovine sequences (data from [ 10,1 t ]) are dis- 
played under the human sequences; the absence of a nucleotide or an amino acid in the bovine sequence indicates that the hum m 
and bovine sequences are the same; the presence of a colon in either nucleotide sequence indicates a gap; the amino acid residw:s 
in the human sequence are numbered, beginning with the tryptophan residue ncoded by the 27th codon, and the preceding resi- 
dues constituting the signal peptide are indicated by negative numbers. Large and small capital etters represent the sequences )f
exons and their surrounding regions, respectively. The exon/intron junctions are positioned according to the GT/AG rule [ 16 J; 
the redundant nucleotide residues at the junctions are underlined. The sequences at both ends of the introns that are compler len- 
tary to the 5'-end of U1 small nuclear RNA are overlined. The putative sites of capping and poty(A) addition are indicated. 7he 
"Hogness box' [ 17] is enclosed with a box. An imperfect palindrome located in the 5'-flanking region is shown by arrows st;~rting 
at its centre above the nucleotide sequence. The sequence of exon 3 of the human gene in [ 18] differs from ours as follow~ (the 
numbers in parentheses refer to the nucleotide numbers of the human exon 3 sequence we determined, beginning with its 5'-end): 
substitutions, A (the residue immediately preceding exon 3), T (6), G (10), C (t 2), G (375), G (414), C (450), C (455), A (618), 
C (695), A (696); deletions (456,472,477,760) ;  additions A (703-704),  T (722--723), G (729-730),  T (796-797).  
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Human 5~- - -GGGGAGCTGC: : : :TCC:TTGT:GCTGCCGGGAAGG: : : :TCAAAGTCCCGCGCCCACCAGG:AGAGCTCG:GCAAG~GGA 
Bov ine  5 ' - - -  T CTGT A G CA TCCAC C TA C GC G C CC A 
~ap 
CAGAGGAGCGC . . . .  GGGA~AAG:CGGCGGCGAAGGAG::: : :~:: :GGGAAGAAGAGCCGCGACCGAGAGAGGCCGCCGAGCGTCC:::~:~::~: 
G c A GAGT : A : C AGAGAACGAA A T::: :: T A A TCGCCCCGGCGC 
: : : : : : : :CCGCCCTCAGAGAG:CAGCCTCCC:GAGACAGG~AAGGGcGc . . . . . . . . . . . .  ( In t ron  A)  . . . . . . . . . . . .  TCTTGTTTGCTTCTG£ 
AGCGGGAG ::::: G T C T c 
-26 -20 -I0 -i 
MetProArgSerCysCysSerArgSerG lyA laLeuLeuLeuA laLeuLeuLeuGlnA laSerMetG luVa lArgGly  
~-dAGCCTCAGCCTGCCTGGAAGATGCCGAGATCGTGC~GCAGCCGC~CGGGGGCCCTGTTGCTGGCCTTGCTGCTTCAGGCCTCCATGGAAGTGCGTGGC 
- CT A T T C C T 
Leu Set  
1 i0 18 
TrpCysLeuGluSerSerG lnCysGlnAspLe~ThrThrG luSerAsnLeuLeu  
TGGTGCCTGGAGAGCAGCCAGTGTCAGGACCTCACCACGGAAAGCAACCTGCTGGTAcGTGGGCCA~Gac . . . . . . . . . . . .  ( In t ron  B) . . . . . . . .  
T ~G G 
19 30 40 
G1 uCys  I leArgA laCysLysProAspLeuSerA laG!  uThrProMetPheProGlyA  snGlyAspGluGlnPr  
. . . .  TGCCCTCGCGTCT : Tc•cc•AGGA••GCA•CC•••CC•GCAAGCCC•ACC•CTCGGCCGAGAC•CCCA•G••CCCG••AAA•••CGAC•AGCA•CC 
C G CG C G --C C G GG C C C T 
Ala  Val 
50 60 70 
oLe uThrG l  uAsnProArgLysTyrVa lMetG lyH isPheArgTrpAspArgPheGlyArgArgAsn  SerSerSerSerG lySerSerG lyA laG ly  
TCTGACCGAGAACCCCCGGAAGTACGTCATGGGCCACTTCCGCTGGGACCGATTCGGCCGCCGCAAC: : : AGCAGCAGCAGCGGCAGCAGCGGCGCAGGG 
G T T C T G TGGT AGTTG G G CC 
Gly Va lG ly  A la  
80 90 i00 
G lnLysArgGluAsp  •a•SerA•aG•yG•uAs••ysG•yPr•LeuPr•G•uG•yG•yPr•G•uPr•ArgSerAs•G•yA laLysPr•G•yPr•ArgG 
CAGAAGCGCGAGGAC : : : •TCTCA•CG••C•AAGACT•C••CCCGC•GC•TGAG••C•GCCCC•A•CCCCGCAGC•A••••GCCAA•CCGGG•CCGC••• 
GGAA GG G T :::::::::::::::::::::::: G G AC G A T 
GIuGlu  A laVa l  G ly  G ly  Asp  G luThr  
I I0  120 130 140 
luG lyLysArgSerTyrSe  rMe tGl uHi sPheArgTrpGl  yLysProVa l  G1 yLysLysArgArgProVa l  LysVa l  TyrProAsnGIyA IaGI  uAspGI  
AGGGCAAGCGCTCCTACTCCATGGAGCACTTCCGCTGGGGCAAGCCGGTGGGCAAGAAGCGGCGCCCAGTGAAGGTGTACCCTAACGGCGCCGAGGACGA 
A T T A G C 
Asp 
150 160 170 
uSerA•aG•uA•a•hePr•LeuG•u•heLysArgG•uLeuThrG•yG•nArgLeuArgG•uG•yAspG•yPr•AspG•y•r•A•aAspAspG•yA•aG•y 
GTCGGCCGAGGCC~TCCCCC~GGAGTTCAAGAGGGAGCTGACTGGCCAGCGACTCCGGGAGGGAGATGGCCCCGACGGCCCTGCCGA~GACGGCGCAGGG 
C T C A C GG A G GA C CGCGC G C AG T GAGT CG C::: 
Gln Glu G luG lnA laArg  G luA laG ln  G luSerA la  
180 190 200 
A IaGI  hAl  aAspLeuGl  uHis  $e rLe uLe uVa lA la  A laG luLysLysAspGluGlyProTyrArgMe t G1 uHi s PheAr  gT 
GCCCAGGCCGACCTGGAGCACAGCCTGCTGGTGGCG: : : : :::: : : : : : : : : :GCCGAGAAGAAGGACGAGGGCCCCTACAGGATGGAGCACTTCCGCT 
G T G T TG : :: GAGGCGGAGGCTGAGGCG TC G T A A 
Arg G lu  TyrG ly  G IuA IaGI  uA laG luA la  Ser  Lys 
210 220 230 
rpG lySer  P roProLy  sAspLysArgTyrG lyG lyPheMetThr  S e rG luLy  sSerG lnThrProLeuVa lThrLeuPheLysAsnA l  aI le I l eLysAs  
GGGGCAGCCCGCCCAAGGACAAGCGCTACGGCGGTTTCATGACCTCCGAGAAGAGCCAGACGCCCcTGGTGACGCTGTTCAAAAACGCCATCATCAAGAA 
T G A T C 
241 
nA laTyrLysLysGlyG lu  
CGCCTACAAGAAGGGCGAGTGAGGGCACAGCGGGCCCCAGGGCTA:CCCTCCCCCAGGAGGTCGACCCCAAAG:CCCCTTGCTCTCCCCTGCCCTGCTGC 
C C G ::: G CT T G G: A A T G G T CT: G :: ::: 
His Gln 
CGCCTCCCAGCCTGGGGGG::::TCGT:::GGCAGATAAT:::::::::::::CAGCCTCTTAAAGCTGCCTGTAGTTAGGAAATAAAACCTTTCAAATT 
G T AGGAT CCCA : G GGCGCCAGGTATC C A T A G 
Po ly (A)  
+ 
TCACATccAcCTCTGACTT::TGAATG---B' 
GAAT :: : GGG T- - -3 '  Fig.2. 
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DNA segments shown in f ig. lB-D were subjected to 
nucleotide sequence analysis according to the strategy 
indicated. 
The human DNA sequence determined is presented 
in fig.2. Comparison with the nucleotide sequence of 
the bovine ACTH-3-LPH precursor gene [ 10,11 ]
enables us to determine the structural organization of 
the human gene. The mRNA-coding sequence of the 
human ACTH-3-LPH precursor gene is divided by 2 
large introns into 3 exons (exon 1, exon 2 and exon 3 
oriented in the direction of transcription). An intron of 
~3.6 kilobase pairs (intron A) interrupts the segment 
encoding the 5'-untranslated region of the mRNA 
between 20 and 21 nucleotide residues upstream from 
the translational initiation site. The other intron of 
~2.9 kilobase pairs (intron B) is located within the 
protein-coding sequence, separating the segment 
encoding the amino-terminal 44 amino acid residues 
including the signal peptide from that encoding the 
whole remaining amino acid residues and the 
3'-untranslated region of the mRNA. Thus, the introns 
of the human gene are located at exactly the same 
positions as those of the bovine counterpart; he 
lengths of intron A and intron B of the bovine gene 
are ~4 and 2.2 kilobase pairs, respectively [10,11]. By 
comparison with the bovine gene sequence, the cap- 
ping site and the poly(A) addition site of the human 
gene have been assigned tentatively. On the basis of 
this assignment and the GT/AG rule for exon/intron 
boundaries [ 16], the lengths of exon 1, exon 2 and 
exon 3 of the human gene are 87,152 and 833 base- 
pairs, respectively;the lengths of the bovine counter- 
parts are 108,. 152 and 838 basepairs, respectively. 
The complete amino acid sequence of the human 
ACTH-3-LPH precursor has been deduced from the 
mRNA-coding sequence. The human precursor pro- 
tein is composed of 267 amino acid residues, having a 
calculated Mr of 29 455; the bovine precursor pro- 
tein consists of 265 amino acid residues. The signal 
peptide, i.e., the amino-terminal 26 amino acid resi- 
dues (review [19]), of the human precursor protein 
exhibits 2 amino acid substitutions as compared with 
the bovine counterpart (Set instead of Leu at residue 
-23;  Cys instead of Set at residue -21). The follow- 
ing 18 amino acid residues encoded by exon 2 are iden- 
tical in the 2 species. A human genomic DNA segment 
containing exon 3 has been isolated and sequenced in
[18]. There are 19 differences between their nucleo- 
tide sequence data and ours as listed in fig.2. Owing 
to some of these differences, our deduced amino acid 
sequence shows the substitution of Arg (residue 22) 
for Gly and that of Asp-Asp-G ly -A la -G ly -A la -  
Gln-Ala (residues 170-177) for A la -Thr -A la -G In -  
Gly-Pro-Gly.  The latter replacement located in the 
region between ACTH and 3-melanotropin (3-MSH) is 
due to shifts of the reading frame resulting from the 
deletion of 3 nucleotide residues in the sequence of 
[ 18]. The other nucleotide differences in the protein- 
coding sequence l ad to synonymous codons. We have 
assigned an additional amino acid residue (Glu) at the 
5'-end of exon 3. 
The sequence of the 76 amino acid residues follow- 
ing the signal peptide of the human ACTH-3-LPH 
precursor deduced from our nucleotide sequence is in 
complete agreement with the sequence of a human 
pituitary glycopeptide determined in [20]. However, 
the amino acid sequence of 7-1ipotropin (7-LPH) 
deduced from our nucleotide sequence disagrees partly 
with that determined in [21 ], which exhibits differ- 
ences in 5 residues (Gln for residue 161 ;Asn for resi- 
due 166; Ala for residue 167; Gly for residue 168;Pro 
for residue 173). The differences observed may be due 
to possible polymorphism in the human gene because 
the DNA sequence we report here is based on analysis 
of a single DNA clone. It cannot be excluded either 
that these differences are due to possible nucleotide 
changes that have occurred uring replication of recom- 
binant DNA. 
Fig.3 illustrates chematically the degree of nucle- 
otide sequence homology in the different structural 
and functional regions of the human and bovine 
ACTtI-3-LPH precursor genes. A high degree of con- 
servation is observed in the segment encoding the 
sequence xtending from the signal peptide to 7-mela- 
notropin (7-MSH), the ACTH region and the segment 
encoding 3-MSH and 3-endorphin. The segments pre- 
ceding and following the ACTH region as well as the 
5'- and 3'-untranslated regions and the segment pre- 
ceding the capping site are moderately conserved. 
Less homology is found in the segment following the 
poly(A) addition site [ 10,11,18]. Tile homology map 
suggests that 7-MSH and the amino-terminal fragment 
lying between the signal peptide and 7-MSH may be 
of physiological importance, as is the case for ACTH 
and 3-endorphin. Examination of the nucleotide 
sequences surrounding the sites of deletion/addition 
in fig.3 reveals the presence of short direct repeats, 
which may be involved in the generation of these 
divergences in the 2 genes as pointed out in the case 
of3-1ike globin genes [23]. The fact that the intron 
1 O0 
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Fig.3. Nucleotide sequence homology in different regions of the human and bovine ACTH-/3-LPH precursor genes. The mRNA- 
coding segment (thick blocks) and the segment preceding it (thin block) are divided into 12 structural and functional regions indi- 
cated by (A-L). Regions of high and moderate homology, based on the corrected percent divergence calculated for each region, 
are shown by dosed and shaded bars, respectively. The open slits represent codons encoding paired basic amino acid residues that 
separate the component peptides, the locations of which are displayed beneath the gene sequence. The sites of capping, transla- 
tional initiation (ATG), translational termination (TGA) and poly(A) addition are shown. (v,t0 Positions of deletion and addition, 
respectively, of ./>9 basepairs in the human sequence as compared with the bovine sequence. The lines indicating introns do not 
represent their real lengths. The corrected percent divergences of replacement substitution sites (r), silent substitution sites (s) and 
total sites (t) of the protein-coding regions and those of the non-coding regions were calculated as in [22]; codons corresponding 
to gaps were excluded from the calculation for replacement and silent substitution sites, whereas gaps were counted as one substi- 
tution ~egardless of their length for the calculation for total sites of the protein-coding regions as well as for the non-coding regions. 
The corrected percent divergences calculated for the regions (A-L) are as follows: A, 29.3; B, 19.5; C, 4.8 (r), 41.6 (s) 11.0 (t); 
D, 1~9 (r), 38.5 (s), 8.8 (t); E, 0 (r), 46.1 (s), 5.8 (t); F, 17.6 (r), >83.9 (s), 37.9 (t); G, 19.3 (r), 27.2 (s), 24.8 (t); H, 1.2 (r), 39.4 
(s), 7.2 (t); I, 30.4 (r), 69.9 (s), 42.4 (t); J, 7.6 (r), 55.0 (s), 12.0 (t); K, 2.9 (r), 31.0 (s), 7.9 (t); L, 26.0. 
sequences adjacent o the exon/ intron junct ions are 
highly conserved suggests the relevance of  these 
sequences to RNA splicing. The complementar i ty  
between the 5'-terrninal sequence o f  U1 small nuclear 
RNA and the consensus equences at both ends of  
introns is considered to be involved in the processing 
of  hnRNA [24,25 ]. 
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